PSA Faye McMillan Conference Grant recipients announced
24 June 2024
The Pharmaceutical Society of Australia (PSA) is proud to announce the recipients of the second annual PSA Faye McMillan Conference Grant.
This grant provides a unique opportunity for recipients to attend the PSA National Conference in Sydney from 2-4 August, supporting the continued professional development of First Nations pharmacists.
Inspired and supported by Professor McMillan herself, the PSA Faye McMillan Conference Grant is awarded each year to Aboriginal and/or Torres Strait Islander pharmacists to attend Australia’s leading pharmacist education conference hosted by PSA.
Thanks to the generosity of this year’s grant sponsors Care Pharmaceuticals and Hydralyte, and AstraZeneca, PSA is proudly supporting three pharmacists to attend PSA24.
The recipients of the PSA Faye McMillan Conference Grant for 2024 are:
- Timothy Hockam
- Elizabeth Dening
- Kirralee Natty
Quotes attributable to Professor Faye McMillan AM FPS:
“Congratulations to all the recipients. Belonging is such a critical aspect of being part of a profession, and the relationship with PSA provides a sense of belonging. I hope all the recipients enjoy every aspect of PSA24, and I look forward to seeing them there.”
Quotes attributable to PSA National President Associate Professor Fei Sim FPS:
“As we celebrate the recipients of the PSA Faye McMillan Conference Grant, PSA reaffirms our commitment to nurturing diversity and inclusion within the pharmacy profession.
“Supporting First Nations pharmacists is not just about equity; it’s about recognising and harnessing the unique perspectives and contributions they bring to the healthcare landscape.
“Congratulations to Timothy, Elizabeth and Kirralee, we are excited to have you as part of this year’s conference.”
Quotes attributable to Marketing Manager of Care Pharmaceuticals and Hydralyte Joan Isaac:
“We are proud sponsors of the PSA Faye McMillan Grant, recognising the remarkable achievements of Indigenous pharmacists like Professor Faye McMillan in advancing healthcare equity. By supporting this initiative, Care Pharmaceuticals and Hydralyte affirm our dedication to fostering inclusivity and diversity within the pharmacy profession, ensuring culturally sensitive care for all.
“As leading providers of innovative healthcare solutions for Australian families, Care Pharmaceuticals and Hydralyte are honoured to sponsor the PSA Faye McMillan Grant. This sponsorship reflects our commitment to empowering Aboriginal and Torres Strait Islander pharmacists to attend the PSA National Conference, contributing to discussions on improving Indigenous healthcare and building a more representative pharmacy workforce for the benefit of all Australians.”
Quotes attributable to Country President of AstraZeneca Australia and New Zealand Ben McDonald:
“Pharmacists are critical to providing front line health care to communities across Australia. Increasing the representation of pharmacists who identify as Aboriginal or Torres Strait Islander is crucial in supporting and delivering culturally appropriate health care.
“AstraZeneca is proud to support the ongoing professional development of First Nations pharmacists by partnering with the PSA’s Faye McMillan Conference Grant.”
PSA24 is a premier platform for pharmacists to exchange knowledge, foster collaborations, and explore innovations shaping the future of healthcare. With the support of the PSA Faye McMillan Conference Grant, these exceptional pharmacists will have the opportunity to engage with peers, expand their skill sets, and contribute to advancing pharmacy practice in Australia.
About Professor Faye McMillan AM
Professor Faye McMillan AM is a Wiradjuri yinaa (woman) originally from Trangie, NSW. She is a dedicated community pharmacist and is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country.
Media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au
